Frequency shift caused by a magnetic field and light intensity inhomogeneity in an optically detected clock.

We present a novel, to the best of our knowledge, frequency shift mechanism in the optically detected atomic clock. This frequency shift is analogous to the light shift that is associated with a detecting light power. However, this shift arises from the inhomogeneity of the magnetic field (C-field) and the detecting light intensity.

Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets.

The immune response holds a pivotal role in cardiovascular disease development. As multifunctional cells of the innate immune system, macrophages play an essential role in initial inflammatory response that occurs following cardiovascular injury, thereby inducing subsequent damage while also facilitating recovery. Meanwhile, the diverse phenotypes and phenotypic alterations of macrophages strongly associate with distinct types and severity of cardiovascular diseases, including coronary heart disease, valvular disease, myocarditis, cardiomyopathy, heart failure, atherosclerosis and aneurysm, which underscores the importance of investigating macrophage regulatory mechanisms within the context of specific diseases.

A new magnetic state selection method in high-performance optically detected compact cesium beam clocks.

We perform a new scheme of magnetic state selection in optically detected compact cesium beam clocks. Unlike the conventional method, we select atoms in the ground state |F = 4, mF ≠ -4⟩ by pointing the atomic collimator to the convex pole of the magnet realizing the two-wire magnetic field and detect atoms in |F = 3⟩ after interacting with the microwave field using a distributed feedback laser. The fluorescence background is greatly reduced as the inherent residual atoms |F = 4, mF = -4⟩ are avoided in this reversed scheme.

Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies.

Chimeric antigen receptor (CAR) T-cell therapy has made remarkable progress in cancer immunotherapy, but several challenges with unclear mechanisms hinder its wide clinical application. Single-cell sequencing technologies, with the powerful unbiased analysis of cellular heterogeneity and molecular patterns at unprecedented resolution, have greatly advanced our understanding of immunology and oncology. In this review, we summarize the recent applications of single-cell sequencing technologies in CAR T-cell therapy, including the biological characteristics, the latest mechanisms of clinical response and adverse events, promising strategies that contribute to the development of CAR T-cell therapy and CAR target selection.

Light shift suppression with pulsed light detection in magnetic-state-selected cesium beam clocks.

Light detection is widely used in atomic clocks. The simple detecting structure induces the light shift which influences the clock's long-term stability. We introduce a new method to suppress light shift by using pulsed light instead of continuous light to detect atomic states.

Donor-derived and off-the-shelf allogeneic anti-CD19 CAR T-cell therapy for R/R ALL and NHL: A systematic review and meta-analysis.

Allogeneic anti-CD19 chimeric antigen receptor (CAR) T-cell therapy has the potential for extensive clinical applications. This study aimed to evaluate its efficacy and safety in treating relapsed or refractory (R/R) acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL). Four databases were searched for relevant studies.

Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies.

Chimeric antigen receptor (CAR) T-cell therapy has yielded impressive outcomes and transformed treatment algorithms for hematological malignancies. To date, five CAR T-cell products have been approved by the US Food and Drug Administration (FDA). Nevertheless, some significant toxicities pose great challenges to the development of CAR T-cell therapy, most notably cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS).

Improving the short-term frequency stability of a magnetic-state-selected cesium beam clock with optical detection.

The microwave spectrum line shape and the signal-to-noise ratio of a compact optically detected magnetic-state-selection cesium beam clock are analyzed in this paper. As the noise analysis shows, the performance is related to the atomic utilization ratio and locking parameters when the laser frequency noise is the dominant noise source. Methods are adopted for realizing better short-term frequency stability of the clock, including using a highly efficient state-selection cesium beam tube, optimizing the locking parameters, and stabilizing the microwave power to maximize the error signal.

Consolidative Hematopoietic Stem Cell Transplantation After CD19 CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: A Systematic Review and Meta-analysis.

Background: This study aimed to systematically evaluate and compare the efficacy and safety of consolidative hematopoietic stem cell transplantation (HSCT) after CD19 chimeric antigen receptor T (CAR-T) therapy with non-HSCT in the treatment of acute lymphoblastic leukemia (ALL).

Methods: The PubMed, Embase, Cochrane Library and Web of Science databases were searched for clinical trials. Pooled hazard ratios (HRs) for overall survival (OS), relapse rate, and leukemia-free survival (LFS) as well as overall incidence rates for transplant-related mortality (TRM), acute graft--host disease (aGVHD), chronic graft--host disease (cGVHD), and infections were calculated using Stata software.

Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments.

Chimeric antigen receptor (CAR) T-cell therapy exhibits desirable and robust efficacy in patients with acute lymphoblastic leukemia (ALL). Stimulated by the revolutionized progress in the use of FDA-approved CD19 CAR T cells, novel agents with CAR designs and targets are being produced in pursuit of superior performance. However, on the path from bench to bedside, new challenges emerge.